Integer Holdings reported third quarter 2026 results, with sales down 3.9% to $450 million and GAAP diluted EPS from continuing operations down 61% to $0.43 from a year earlier. The company gave no financial outlook because its pending acquisition by an affiliate of KKR-managed investment funds is expected to close by the end of 2026, subject to remaining conditions including regulatory approvals.
Sales fell 3.9% to $450 million; organic sales fell 2.2%, with Cardio & Vascular down 5% and Other Markets down 49.7% on the Portable Medical exit.
GAAP operating income was $28 million, down 50%; GAAP income from continuing operations was $15 million, down 62%.
Non-GAAP adjusted EPS was $1.34, down 25%; adjusted EBITDA was $88 million, down 17%.
Total debt rose $34 million to $1.219 billion since year-end 2025; no financial outlook was provided, and stockholders approved the merger on October 21, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Integer Holdings Corporation's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$1.85B
+8.0%
$2.89
-14.0%
5.5%
FY2024
$1.72B
+10.3%
$3.36
+24.9%
7.0%
FY2023
$1.56B
+16.9%
$2.69
+35.2%
5.8%
FY2022
$1.33B
+9.0%
$1.99
-31.6%
5.0%
FY2021
$1.22B
+13.8%
$2.91
+24.9%
7.9%
Frequently asked questions
When is Integer Holdings's next earnings date?
Integer Holdings has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Integer Holdings earn last quarter?
For the quarter ended Oct 2026, Integer Holdings reported diluted EPS of $0.43 (-61.3% year over year) on revenue of $449.66M (-3.9%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.